Blood Thinner Injury Lawyers
Pradaxa® and Eliquis® Linked to Severe Bleeding
Traditionally, anticoagulant drugs are prescribed to help reduce blood clots that can cause heart attacks, stroke, or cardiovascular death. Warfarin (marketed as Coumadin®) has been used for half a century. However, over the last decade, several next-generation anticoagulants — including Pradaxa® and Eliquis® — have been approved by the U.S. Food and Drug Administration (FDA).
Both drugs have been linked to an increased risk of severe bleeding. And unlike Warfarin, Eliquis has no counteracting agents to stop bleeding once it begins, which may lead to severe injuries or even death.
If you or someone you love suffered severe bleeding or other injuries after taking Pradaxa or Eliquis, call the Louisiana drug injury attorneys at Dudley DeBosier Injury Lawyers today. Our firm has years of experience fighting for the rights of injured victims, and we’re ready to help you, too. Complete our free initial consultation form to get started.
Pradaxa® Bleeding Lawsuit Settlements
Pradaxa (dabigatran), a prescription blood-thinning drug, was approved by the FDA in 2010 and is used to reduce stroke risk in non-valvular atrial fibrillation (AFib) patients. Four years later, the FDA published a study that revealed patients age 65 and older taking Pradaxa faced a higher risk of gastrointestinal bleeding than patients taking Warfarin.
Due to these significant risks, thousands of victims and their families have brought lawsuits against Pradaxa manufacturer Boehringer Ingelheim, leading to settlements totaling more than $650 million to date.
Eliquis® Severe Bleeding Threat
Although it was approved by the FDA after Pradaxa, Eliquis presents many of the same severe bleeding risks. In addition, patients taking Eliquis may suffer from:
- Blood clots
- Gastrointestinal bleeding
- Hemorrhagic stroke (brain bleeding)
- Intracranial bleeding (bleeding in the skull)
You Deserve Compensation for Your Injuries
If you or someone you love took a blood-thinning medication such as Pradaxa or Eliquis and suffered from severe bleeding, stroke, or blood clots, we may be able to help. Don’t take on the pharmaceutical companies alone. Let our Louisiana drug injury lawyers fight to get the compensation you deserve, and contact Dudley DeBosier Injury Lawyers today.
Coumadin® and Eliquis® are registered trademarks of Bristol-Myers Squibb Company and are used here only for the purpose of identifying the products in question. Pradaxa® is a registered trademark of Boehringer Ingelheim and is used here only for the purpose of identifying the product in question.
Dudley DeBosier Injury Lawyers is not associated with, sponsored by, or affiliated with Boehringer Ingelheim; Bristol-Myers Squibb Company; or the U.S. Food and Drug Administration.
Do not stop taking a prescription medication without first consulting with your doctor. Discontinuing a prescribed medication without your doctor’s advice can result in injury or death.
Cases may be referred to another attorney or law firm.
